{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:02:24Z","timestamp":1784340144717,"version":"3.55.0"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"1","funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["KUN2012-5366"],"award-info":[{"award-number":["KUN2012-5366"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF17CC0027852"],"award-info":[{"award-number":["NNF17CC0027852"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R35 CA297695"],"award-info":[{"award-number":["R35 CA297695"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P50 CA021765"],"award-info":[{"award-number":["P50 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"publisher","award":["154293"],"award-info":[{"award-number":["154293"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"publisher","award":["#130412"],"award-info":[{"award-number":["#130412"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"publisher","award":["#89932"],"award-info":[{"award-number":["#89932"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["#703212"],"award-info":[{"award-number":["#703212"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Central nervous system (CNS) dissemination of B-precursor acute lymphoblastic leukemia (B-ALL) has poor prognosis and remains a therapeutic challenge. Here we performed targeted DNA sequencing as well as transcriptional and proteomic profiling of paired leukemia-infiltrating cells in the bone marrow (BM) and CNS of xenografts. Genes governing mRNA translation were upregulated in CNS leukemia, and subclonal genetic profiling confirmed this in both BM-concordant and BM-discordant CNS mutational populations. CNS leukemia cells were exquisitely sensitive to the translation inhibitor omacetaxine mepesuccinate, which reduced xenograft leptomeningeal disease burden. Proteomics demonstrated greater abundance of secreted proteins in CNS-infiltrating cells, including complement component 3 (C3), and drug targeting of C3 influenced CNS disease in xenografts. CNS-infiltrating cells also exhibited selection for stemness traits and metabolic reprogramming. Overall, our study identifies targeting of mRNA translation as a potential therapeutic approach for B-ALL leptomeningeal disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Cancer metastases are often driven by distinct subclones with unique biological properties. Here we show that in B-ALL CNS disease, the leptomeningeal environment selects for cells with unique functional dependencies. Pharmacologic inhibition of mRNA translation signaling treats CNS disease and offers a new therapeutic approach for this condition.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 1<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-20-0216","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T10:35:53Z","timestamp":1633948553000},"page":"16-31","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target"],"prefix":"10.1158","volume":"3","author":[{"given":"Robert J.","family":"Vanner","sequence":"first","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."},{"name":"2Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Dobson","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Gan","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"McLeod","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-7832","authenticated-orcid":false,"given":"Erwin M.","family":"Schoof","sequence":"additional","affiliation":[{"name":"3Technical University of Denmark (DTU), Lyngby, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Grandal","sequence":"additional","affiliation":[{"name":"4Genetics and Genome Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-9470","authenticated-orcid":false,"given":"Jeff A.","family":"Wintersinger","sequence":"additional","affiliation":[{"name":"5Department of Computer Science, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garcia-Prat","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Hosseini","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-494X","authenticated-orcid":false,"given":"Stephanie Z.","family":"Xie","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Jin","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Mbong","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-9532","authenticated-orcid":false,"given":"Veronique","family":"Voisin","sequence":"additional","affiliation":[{"name":"6Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, Ontario, Canada."},{"name":"7Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-9354","authenticated-orcid":false,"given":"Michelle","family":"Chan-Seng-Yue","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-953X","authenticated-orcid":false,"given":"Esm\u00e9","family":"Waanders","sequence":"additional","affiliation":[{"name":"8Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, the Netherlands."},{"name":"9Department of Genetics, University Medical Center, Utrecht, the Netherlands."},{"name":"10Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quaid","family":"Morris","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."},{"name":"4Genetics and Genome Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada."},{"name":"5Department of Computer Science, University of Toronto, Toronto, Ontario, Canada."},{"name":"6Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, Ontario, Canada."},{"name":"11Ontario Institute for Cancer Research, Toronto, Ontario, Canada."},{"name":"12Vector Institute, Toronto, Ontario, Canada."},{"name":"13Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-0844","authenticated-orcid":false,"given":"Bo","family":"Porse","sequence":"additional","affiliation":[{"name":"14The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark."},{"name":"15Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark."},{"name":"16Danish Stem Cell Centre (DanStem), University of Copenhagen, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Chan","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7674-2612","authenticated-orcid":false,"given":"Cynthia J.","family":"Guidos","sequence":"additional","affiliation":[{"name":"17Department of Immunology, University of Toronto, Toronto, Ontario, Canada."},{"name":"18Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne S.","family":"Danska","sequence":"additional","affiliation":[{"name":"4Genetics and Genome Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada."},{"name":"17Department of Immunology, University of Toronto, Toronto, Ontario, Canada."},{"name":"18Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."},{"name":"2Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"10Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-8317","authenticated-orcid":false,"given":"John E.","family":"Dick","sequence":"additional","affiliation":[{"name":"1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada."},{"name":"2Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"7Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada."},{"name":"11Ontario Institute for Cancer Research, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"2025112416464518000_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","article-title":"Central nervous system disease in hematologic malignancies: historical perspective and practical applications","volume":"36","author":"Pui","year":"2009","journal-title":"Semin Oncol"},{"key":"2025112416464518000_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.blre.2019.04.003","article-title":"Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: reconciling biological concepts and clinical issues","volume":"36","author":"Gaudichon","year":"2019","journal-title":"Blood Rev"},{"key":"2025112416464518000_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","article-title":"Current management and challenges of malignant disease in the CNS in paediatric leukaemia","volume":"9","author":"Pui","year":"2008","journal-title":"Lancet Oncol"},{"key":"2025112416464518000_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"2025112416464518000_bib5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"2025112416464518000_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.14411","article-title":"Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy","volume":"176","author":"Frishman-Levy","year":"2017","journal-title":"Br J Haematol"},{"key":"2025112416464518000_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/2159-8290.CD-19-1059","article-title":"Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs","volume":"10","author":"Dobson","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112416464518000_bib8","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2016-06-721712","article-title":"Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA","volume":"129","author":"Kato","year":"2017","journal-title":"Blood"},{"key":"2025112416464518000_bib9","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood-2015-08-665034","article-title":"The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts","volume":"127","author":"Williams","year":"2016","journal-title":"Blood"},{"key":"2025112416464518000_bib10","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/leu.2017.140","article-title":"Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia","volume":"122","author":"Elder","year":"2017","journal-title":"Leukemia"},{"key":"2025112416464518000_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature09650","article-title":"Genetic variegation of clonal architecture and propagating cells in leukaemia","volume":"469","author":"Anderson","year":"2011","journal-title":"Nature"},{"key":"2025112416464518000_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"key":"2025112416464518000_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2017-03-769315","article-title":"Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor","volume":"130","author":"M\u00fcnch","year":"2017","journal-title":"Blood"},{"key":"2025112416464518000_bib14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2018-04-844209","article-title":"IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"132","author":"Alsadeq","year":"2018","journal-title":"Blood"},{"key":"2025112416464518000_bib15","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1200\/JCO.2007.11.8166","article-title":"High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS","volume":"25","author":"Cario","year":"2007","journal-title":"J Clin Oncol"},{"key":"2025112416464518000_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41586-018-0342-5","article-title":"Leukaemia hijacks a neural mechanism to invade the central nervous system","volume":"560","author":"Yao","year":"2018","journal-title":"Nature"},{"key":"2025112416464518000_bib17","article-title":"Reconstructing complex cancer evolutionary histories from multiple bulk DNA samples using Pairtree.","volume-title":"BioRxiv","author":"Wintersinger","year":"2021"},{"key":"2025112416464518000_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3324\/haematol.2016.147744","article-title":"The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system","volume":"102","author":"Alsadeq","year":"2017","journal-title":"Haematologica"},{"key":"2025112416464518000_bib19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s43018-020-00115-2","article-title":"Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment depends on stearoyl-CoA desaturase","volume":"1","author":"Savino","year":"2020","journal-title":"Nat Cancer"},{"key":"2025112416464518000_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barabe","year":"2007","journal-title":"Science"},{"key":"2025112416464518000_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"key":"2025112416464518000_bib22","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416464518000_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","article-title":"Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia","volume":"30","author":"Ebinger","year":"2016","journal-title":"Cancer Cell"},{"key":"2025112416464518000_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"2025112416464518000_bib25","article-title":"Single-cell analysis reveals mechanisms of plasticity in leukemia initiating cells","author":"Morris","year":"2021"},{"key":"2025112416464518000_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00162769","article-title":"Central nervous system (CNS) penetration of homoharringtonine (HHT)","volume":"5","author":"Savaraj","year":"1987","journal-title":"J Neurooncol"},{"key":"2025112416464518000_bib27","first-page":"1245","article-title":"Phase I trial of homoharringtonine in children with refractory leukemia","volume":"71","author":"Tan","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"2025112416464518000_bib28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1126\/science.aay0939","article-title":"Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis","volume":"367","author":"Ebright","year":"2020","journal-title":"Science"},{"key":"2025112416464518000_bib29","doi-asserted-by":"crossref","first-page":"(suppl; abstr 6513)","DOI":"10.1200\/jco.2012.30.15_suppl.6513","article-title":"Subcutaneous omacetaxine mepesuccinate in patients with chronic phase (CP) or accelerated phase (AP) chronic myeloid leukemia (CML) resistant\/intolerant to two or three approved tyrosine-kinase inhibitors (TKIs)","volume":"30","author":"Nicolini","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025112416464518000_bib30","doi-asserted-by":"crossref","first-page":"359ra129","DOI":"10.1126\/scitranslmed.aaf3735","article-title":"Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia","volume":"8","author":"Lam","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025112416464518000_bib31","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/onc.2014.146","article-title":"Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3","volume":"34","author":"Robichaud","year":"2015","journal-title":"Oncogene"},{"key":"2025112416464518000_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"2025112416464518000_bib33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ccell.2016.10.004","article-title":"UNR\/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis","volume":"30","author":"Wurth","year":"2016","journal-title":"Cancer Cell"},{"key":"2025112416464518000_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2018.02.036","article-title":"Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis","volume":"173","author":"Khajuria","year":"2018","journal-title":"Cell"},{"key":"2025112416464518000_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molcel.2017.05.021","article-title":"Heterogeneous ribosomes preferentially translate distinct subpools of mRNAs genome-wide","volume":"67","author":"Shi","year":"2017","journal-title":"Mol Cell"},{"key":"2025112416464518000_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - the \u201cSwiss Army Knife\u201d of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol Rev"},{"key":"2025112416464518000_bib37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"key":"2025112416464518000_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res"},{"key":"2025112416464518000_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc.2017.30","article-title":"New frontiers in translational control of the cancer genome","volume":"17","author":"Truitt","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2025112416464518000_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2025112416464518000_bib41","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41556-019-0415-1","article-title":"Translational reprogramming marks adaptation to asparagine restriction in cancer","volume":"21","author":"Pathria","year":"2019","journal-title":"Nat Cell Biol"},{"key":"2025112416464518000_bib42","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3324\/haematol.2018.206433","article-title":"Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study","volume":"104","author":"Rizzari","year":"2019","journal-title":"Haematologica"},{"key":"2025112416464518000_bib43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.blre.2017.06.002","article-title":"Catalyzing improvements in ALL therapy with asparaginase","volume":"31","author":"Marini","year":"2017","journal-title":"Blood Rev"},{"key":"2025112416464518000_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exphem.2020.04.007","article-title":"Epigenetic regulation of protein translation in KMT2A-rearranged AML","volume":"85","author":"Lenard","year":"2020","journal-title":"Exp Hematol"},{"key":"2025112416464518000_bib45","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1038\/s41598-020-64929-x","article-title":"Single-cell analysis of childhood leukemia reveals a link between developmental states and ribosomal protein expression as a source of intra-individual heterogeneity","volume":"10","author":"Caron","year":"2020","journal-title":"Sci Rep"},{"key":"2025112416464518000_bib46","first-page":"1","article-title":"Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice","volume":"23","author":"Chen","year":"2019","journal-title":"Leukemia"},{"key":"2025112416464518000_bib47","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2025112416464518000_bib48","doi-asserted-by":"crossref","first-page":"e140966","DOI":"10.1172\/JCI140966","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J Clin Invest"},{"key":"2025112416464518000_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molimm.2014.06.039","article-title":"Complement and blood\u2013brain barrier integrity","volume":"61","author":"Jacob","year":"2014","journal-title":"Mol Immunol"},{"key":"2025112416464518000_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1078-0432.CCR-19-2840","article-title":"Proteomic analysis of CSF from patients with leptomeningeal melanoma metastases identifies signatures associated with disease progression and therapeutic resistance","volume":"26","author":"Smalley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025112416464518000_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-016-0055-6","article-title":"A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia","volume":"4","author":"Cavalcante Mde","year":"2016","journal-title":"Biomarker Res"},{"key":"2025112416464518000_bib52","doi-asserted-by":"crossref","first-page":"pdb.prot5439","DOI":"10.1101\/pdb.prot5439","article-title":"Purification of RNA using TRIzol (TRI reagent)","volume":"2010","author":"Rio","year":"2010","journal-title":"Cold Spring Harb Protoc"},{"key":"2025112416464518000_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025112416464518000_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2014","journal-title":"Bioinformatics"},{"key":"2025112416464518000_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2025112416464518000_bib56","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2025112416464518000_bib57","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.12688\/f1000research.9090.1","article-title":"AutoAnnotate: a Cytoscape app for summarizing networks with semantic annotations","volume":"5","author":"Kucera","year":"2016","journal-title":"F1000Res"},{"key":"2025112416464518000_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1751-0473-6-7","article-title":"WordCloud: a Cytoscape plugin to create a visual semantic summary of networks","volume":"6","author":"Oesper","year":"2011","journal-title":"Source Code Biol Med"},{"key":"2025112416464518000_bib59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccell.2015.12.011","article-title":"miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells","volume":"29","author":"Lechman","year":"2016","journal-title":"Cancer Cell"},{"key":"2025112416464518000_bib60","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2025112416464518000_bib61","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025112416464518000_bib62","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/1471-2105-12-436","article-title":"clusterMaker: a multi-algorithm clustering plugin for Cytoscape","volume":"12","author":"Morris","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2025112416464518000_bib63","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"2025112416464518000_bib64","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1541-0420.2011.01616.x","article-title":"ggplot2: elegant graphics for data analysis by WICKHAM, H","volume":"67","author":"Wilkinson","year":"2011","journal-title":"Biometrics"},{"key":"2025112416464518000_bib65","first-page":"1","article-title":"gplots: various R programming tools for plotting data","author":"Warnes","year":"2009"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/1\/16\/3524800\/16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/1\/16\/3524800\/16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:47:01Z","timestamp":1764020821000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/3\/1\/16\/675478\/Multiomic-Profiling-of-Central-Nervous-System"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,10,7]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-20-0216","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.28001146","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698608","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.28001143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698614","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.28001152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698617","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698611","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.28001149","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.7088992","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}